These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 13962571)

  • 1. New findings in the immunobiological study of typhoid carriers and of anti-typhoid immunity.
    KAROLCEK J; DRASKOVICOVA M; ODLER I
    J Hyg Epidemiol Microbiol Immunol; 1962; 6():436-41. PubMed ID: 13962571
    [No Abstract]   [Full Text] [Related]  

  • 2. [USE OF SEROLOGICO-IMMUNOBIOLOGICAL METHODS IN THE DIAGNOSIS OF TYPHOID CARRIERS].
    KAROLCEK J; ODLER I; DRASKOVICOVA M; LUZOVA D
    Cesk Epidemiol Mikrobiol Imunol; 1963 Jul; 12():215-9. PubMed ID: 14073563
    [No Abstract]   [Full Text] [Related]  

  • 3. THE BASIS FOR IMMUNITY TO MOUSE TYPHOID. 2. ANTIBODY FORMATION DURING THE CARRIER STATE.
    TURNER KJ; JENKIN CR; ROWLEY D
    Aust J Exp Biol Med Sci; 1964 Apr; 42():229-36. PubMed ID: 14150757
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE NUMBER OF TYPHOID AND PARATYPHOID BACTERIA CARRIERS IN THE NEUBRANDENBURG DISTRICT AND THEIR DISTRIBUTION AMONG THE POPULATION].
    BIERSCHENK H
    Z Arztl Fortbild (Jena); 1964 Mar; 58():328-35. PubMed ID: 14171606
    [No Abstract]   [Full Text] [Related]  

  • 5. THE BASIS FOR IMMUNITY TO MOUSE TYPHOID. I. THE CARRIER STATE.
    JENKIN CR; ROWLEY D; AUZINS I
    Aust J Exp Biol Med Sci; 1964 Apr; 42():215-28. PubMed ID: 14150756
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical-epidemiological parallels in patients suffering from typhoid and paratyphoid fever treated with levomycetin in combination with vaccine].
    Musabaev IK; Nevskiĭ MV; Ambartsumov SM; Mikhaĭlovskaia OG; Kotiuminskaia NA; David'ian AO
    Sov Med; 1966 Jun; 29(6):64-9. PubMed ID: 4965445
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of patients with typhoid and paratyphoid fever by use of typhoid-paratyphoid B vaccines with the aim of prevention of carrier state formation].
    Bilibin AF; Kornilova II; Antonova IV; Kilesso VA; Riadneva OE; Taratorina OM; Izmaĭlova NB; Khazanova LE
    Klin Med (Mosk); 1965 Aug; 43(8):112-7. PubMed ID: 4957973
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of Vi-agglutination in the detection of typhoid carriers; a contribution to the tropical epidemiology of typhoid].
    de GRAAF W
    Med Maandbl; 1950 Dec; 3(12):544-53. PubMed ID: 24540131
    [No Abstract]   [Full Text] [Related]  

  • 9. AMPICILLIN FOR TYPHOID CARRIERS.
    CHRISTIE AB
    Br Med J; 1964 Oct; 2(5413):876. PubMed ID: 14191895
    [No Abstract]   [Full Text] [Related]  

  • 10. An epidemiological report of a typhoid case and carrier.
    WILZBACH CA
    Cinci J Med; 1949 Mar; 30(3):176. PubMed ID: 18112471
    [No Abstract]   [Full Text] [Related]  

  • 11. [The sterilization of typhoid carriers with a new antibiotic: paromomycin].
    FRANCO F; BOTTECCHIA G
    G Veneto Sci Med; 1961; 16():483-9. PubMed ID: 13894539
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of typhoid carriers with chloromycetin].
    MARTORANA F
    Riv Ital Ig; 1950; 10(1-2):17-21. PubMed ID: 15441888
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of typhoid carriers with chloramphenicol.
    NICHOLS DR
    J Lab Clin Med; 1950 Dec; 36(6):971-2. PubMed ID: 14795055
    [No Abstract]   [Full Text] [Related]  

  • 14. AMPICILLIN FOR TYPHOID CARRIERS.
    TROY P
    Br Med J; 1964 Sep; 2(5411):756. PubMed ID: 14172049
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of Vi-agglutination in the detection of typhoid carriers].
    WILDFUHR G
    Z Gesamte Inn Med; 1951 Mar; 6(5-6):158-60. PubMed ID: 14836908
    [No Abstract]   [Full Text] [Related]  

  • 16. [Case finding of typhoid carriers by Vi serodiagnosis].
    SAINT-MARTIN M; DESRANLEAU JM
    Union Med Can; 1951 Jun; 80(6):690-6. PubMed ID: 14836031
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anti-typhoid vaccine prophylaxis and vaccine therapy in carrier states and in typhoid fever. I. Convalescent carriers].
    Buşilă VT; Vasilescu I; Vâlceanu M; Fitărău A; Pintea L
    Microbiol Parazitol Epidemiol (Bucur); 1970; 15(4):305-11. PubMed ID: 5456200
    [No Abstract]   [Full Text] [Related]  

  • 18. [ON THE SANITIZATION OF CHRONIC CARRIERS OF TYPHOID BACTERIA].
    ESSEN KW; KIRSCHNICK R
    Dtsch Med J; 1964 Nov; 15():750-2. PubMed ID: 14329917
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of chronic typhoid carriers with terramycin.
    KORNS RF; ALBRECHT RM
    J Lab Clin Med; 1951 Oct; 38(4):617-9. PubMed ID: 14889044
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinico-immunological mechanisms in typhoid and formation of bacteria carrier state].
    Bunin KV; Bunin MV
    Klin Med (Mosk); 1975 Feb; 53(2):3-10. PubMed ID: 1186056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.